MGO One Seven’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.4M | Buy |
28,700
+2,574
| +10% | +$2.61M | 0.53% | 29 |
|
|
2025
Q4 | $28.1M | Sell |
26,126
-196
| -0.7% | -$187K | 0.57% | 27 |
|
|
2025
Q3 | $20.1M | Buy |
26,322
+2,567
| +11% | +$1.91M | 0.46% | 36 |
|
|
2025
Q2 | $18.5M | Sell |
23,755
-533
| -2% | -$414K | 0.6% | 22 |
|
|
2025
Q1 | $20.1M | Buy |
24,288
+8,579
| +55% | +$7.14M | 0.78% | 16 |
|
|
2024
Q4 | $12.1M | Buy |
15,709
+54
| +0.3% | +$44.7K | 0.46% | 39 |
|
|
2024
Q3 | $13.9M | Buy |
15,655
+1,922
| +14% | +$1.73M | 0.6% | 27 |
|
|
2024
Q2 | $12.4M | Buy |
13,733
+5,106
| +59% | +$4.08M | 0.59% | 25 |
|
|
2024
Q1 | $6.71M | Sell |
8,627
-205
| -2% | -$146K | 0.35% | 68 |
|
|
2023
Q4 | $5.15M | Sell |
8,832
-338
| -4% | -$197K | 0.3% | 83 |
|
|
2023
Q3 | $4.93M | Buy |
9,170
+980
| +12% | +$505K | 0.38% | 64 |
|
|
2023
Q2 | $3.84M | Buy |
8,190
+299
| +4% | +$125K | 0.35% | 60 |
|
|
2023
Q1 | $2.71M | Buy |
7,891
+1,064
| +16% | +$359K | 0.17% | 152 |
|
|
2022
Q4 | $2.5M | Buy |
6,827
+264
| +4% | +$93.6K | 0.25% | 98 |
|
|
2022
Q3 | $2.44K | Sell |
6,563
-1,594
| -20% | -$505K | 0.09% | 128 |
|
|
2022
Q2 | $2.65M | Sell |
8,157
-762
| -9% | -$229K | 0.36% | 63 |
|
|
2022
Q1 | $2.55M | Sell |
8,919
-133
| -1% | -$34.2K | 0.27% | 86 |
|
|
2021
Q4 | $2.5M | Buy |
9,052
+1,506
| +20% | +$382K | 0.26% | 93 |
|
|
2021
Q3 | $1.92M | Buy |
7,546
+70
| +0.9% | +$17.3K | 0.24% | 107 |
|
|
2021
Q2 | $1.72M | Buy |
7,476
+804
| +12% | +$162K | 0.24% | 112 |
|
|
2021
Q1 | $1.25M | Sell |
6,672
-1,255
| -16% | -$245K | 0.21% | 118 |
|
|
2020
Q4 | $1.34M | Sell |
7,927
-645
| -8% | -$96.3K | 0.28% | 89 |
|
|
2020
Q3 | $1.27M | Sell |
8,572
-1,196
| -12% | -$185K | 0.3% | 78 |
|
|
2020
Q2 | $1.6M | Sell |
9,768
-1,631
| -14% | -$250K | 0.42% | 52 |
|
|
2020
Q1 | $1.58M | Sell |
11,399
-930
| -8% | -$128K | 0.54% | 47 |
|
|
2019
Q4 | $1.62M | Sell |
12,329
-1,396
| -10% | -$162K | 0.42% | 59 |
|
|
2019
Q3 | $1.53M | Buy |
13,725
+132
| +1% | +$14.7K | 0.44% | 56 |
|
|
2019
Q2 | $1.5M | Sell |
13,593
-1,050
| -7% | -$124K | 0.49% | 50 |
|
|
2019
Q1 | $1.9M | Buy |
14,643
+4,786
| +49% | +$582K | 0.62% | 34 |
|
|
2018
Q4 | $1.14M | Sell |
9,857
-246
| -2% | -$27.5K | 0.49% | 39 |
|
|
2018
Q3 | $1.08M | Buy |
+10,103
| New | +$1.01M | 0.51% | 42 |
|
|
2018
Q1 | $675K | Sell |
8,721
-275
| -3% | -$22.1K | 0.31% | 82 |
|
|
2017
Q4 | $760K | Buy |
+8,996
| New | +$765K | 0.35% | 73 |
|
Other funds holding LLY
VCM
VPM
MGO One Seven's LLY Position: Q1 2026 in Review
MGO One Seven increased its Eli Lilly (LLY) stake by 9.9% in Q1 2026, buying an estimated $2.61M and bringing the position to 28,700 shares worth $26.4M. The position accounts for 0.53% of the portfolio, ranked #29.
MGO One Seven first reported a position in LLY in Q4 2017 and has held it in 33 quarters since. The position peaked at $28.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- MGO One Seven held 28,700 shares of Eli Lilly worth $26.4M as of Q1 2026.
- MGO One Seven bought 2,574 Eli Lilly shares in Q1 2026, an estimated $2.61M.
- Eli Lilly made up 0.53% of MGO One Seven's portfolio in Q1 2026, its #29 holding.
- MGO One Seven first reported a position in Eli Lilly in Q4 2017 and has held it in 33 quarters since.
- MGO One Seven's Eli Lilly position peaked at $28.1M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.